JP2011516410A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516410A5
JP2011516410A5 JP2010548040A JP2010548040A JP2011516410A5 JP 2011516410 A5 JP2011516410 A5 JP 2011516410A5 JP 2010548040 A JP2010548040 A JP 2010548040A JP 2010548040 A JP2010548040 A JP 2010548040A JP 2011516410 A5 JP2011516410 A5 JP 2011516410A5
Authority
JP
Japan
Prior art keywords
fibrosis
modified
compound according
compound
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010548040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516410A (ja
JP6033527B2 (ja
Filing date
Publication date
Priority claimed from EP20080003570 external-priority patent/EP2096171A1/en
Application filed filed Critical
Publication of JP2011516410A publication Critical patent/JP2011516410A/ja
Publication of JP2011516410A5 publication Critical patent/JP2011516410A5/ja
Application granted granted Critical
Publication of JP6033527B2 publication Critical patent/JP6033527B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010548040A 2008-02-27 2009-02-26 診断および治療のためのミクロＲＮＡ（ｍｉＲＮＡ）および下流標的 Expired - Fee Related JP6033527B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US3183508P 2008-02-27 2008-02-27
EP20080003570 EP2096171A1 (en) 2008-02-27 2008-02-27 MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes
EP08003570.2 2008-02-27
US61/031,835 2008-02-27
US3334008P 2008-03-03 2008-03-03
US61/033,340 2008-03-03
EPPCT/EP2009/051986 2009-02-19
PCT/EP2009/051986 WO2009106477A1 (en) 2008-02-27 2009-02-19 Microrna (mirna) and down-stream targets for diagnostic and therapeutic purposes
PCT/EP2009/001590 WO2009106367A1 (en) 2008-02-27 2009-02-26 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014246185A Division JP2015107971A (ja) 2008-02-27 2014-12-04 診断および治療のためのミクロＲＮＡ（ｍｉＲＮＡ）および下流標的

Publications (3)

Publication Number Publication Date
JP2011516410A JP2011516410A (ja) 2011-05-26
JP2011516410A5 true JP2011516410A5 (enExample) 2013-01-17
JP6033527B2 JP6033527B2 (ja) 2016-11-30

Family

ID=39639202

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010548040A Expired - Fee Related JP6033527B2 (ja) 2008-02-27 2009-02-26 診断および治療のためのミクロＲＮＡ（ｍｉＲＮＡ）および下流標的
JP2014246185A Pending JP2015107971A (ja) 2008-02-27 2014-12-04 診断および治療のためのミクロＲＮＡ（ｍｉＲＮＡ）および下流標的

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014246185A Pending JP2015107971A (ja) 2008-02-27 2014-12-04 診断および治療のためのミクロＲＮＡ（ｍｉＲＮＡ）および下流標的

Country Status (23)

Country Link
US (10) US8236777B2 (enExample)
EP (3) EP2096171A1 (enExample)
JP (2) JP6033527B2 (enExample)
KR (1) KR101697482B1 (enExample)
CN (1) CN102027113B (enExample)
AU (1) AU2009218704C1 (enExample)
BR (1) BRPI0907565B1 (enExample)
CA (2) CA3123067A1 (enExample)
CY (1) CY1114426T1 (enExample)
DK (1) DK2260101T3 (enExample)
EA (1) EA020335B1 (enExample)
ES (1) ES2436885T3 (enExample)
HR (1) HRP20130766T1 (enExample)
IL (1) IL207704A (enExample)
ME (1) ME01600B (enExample)
MX (2) MX2010009346A (enExample)
MY (1) MY159454A (enExample)
NZ (1) NZ588185A (enExample)
PL (1) PL2260101T3 (enExample)
PT (1) PT2260101E (enExample)
SI (1) SI2260101T1 (enExample)
UA (1) UA100727C2 (enExample)
WO (2) WO2009106477A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2534300T3 (es) 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
EP2096171A1 (en) 2008-02-27 2009-09-02 Julius-Maximilians-Universität Würzburg MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes
WO2011017697A1 (en) * 2009-08-07 2011-02-10 New York University Compositions and methods for treating inflammatory disorders
CN102038959B (zh) * 2009-10-26 2012-12-19 中国科学院上海生命科学研究院 let-7/miR-98家族在制备治疗FAS基因相关疾病的药物中的应用
WO2011126842A2 (en) * 2010-03-30 2011-10-13 Regulus Therapeutics Inc. Targeting micrornas for the treatment of cardiac disorders
US20130150256A1 (en) 2010-06-11 2013-06-13 Jane Synnergren Novel micrornas for the detection and isolation of human embryonic stem cell-derived cardiac cell types
WO2012012716A2 (en) 2010-07-23 2012-01-26 Regulus Therapeutics, Inc. Targeting micrornas for the treatment of fibrosis
EP2652151A2 (en) * 2010-12-15 2013-10-23 Miragen Therapeutics Microrna inhibitors comprising locked nucleotides
MX393138B (es) 2011-04-25 2025-03-24 Sanofi Sa Compuestos de microarn y metodos para modular la actividad de mir-21.
EP4008786A3 (en) * 2011-09-06 2022-08-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. The mirna-212/132 family as a therapeutic target
EP2763703B1 (en) 2011-10-06 2018-02-14 Miragen Therapeutics, Inc. Control of whole body energy homeostasis by microrna regulation
EP2592145A1 (en) * 2011-11-11 2013-05-15 Medizinische Hochschule Hannover Medicament for the treatment of cardiac disease
BR112014012288A2 (pt) * 2011-11-22 2017-05-23 Intermune Inc métodos para diagnosticar e tratar fibrose pulmonar idiopática
EP2790735A4 (en) * 2011-12-13 2015-12-09 Ohio State Innovation Foundation METHODS AND COMPOSITIONS RELATING TO MIR-21 AND MIR-29A, EXOSOME INHIBITION, AND CANCER METASTASIS
US9193971B2 (en) 2012-04-10 2015-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for the treatment of nonalcoholic steatohepatitis
MY173600A (en) 2012-04-25 2020-02-08 Sanofi Sa Microrna compounds and methods for modulating mir-21 activity
EP2864482A4 (en) 2012-06-21 2016-02-10 Miragen Therapeutics Inc OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN
CA2782942C (en) 2012-07-12 2019-08-27 Canadian Blood Services Method for inducing immune tolerance using polymer-modified antigenic leukocytes
UA116639C2 (uk) * 2012-10-09 2018-04-25 Рег'Юлес Терап'Ютікс Інк. Способи лікування синдрому альпорта
EP3019176B1 (en) 2013-07-12 2020-05-06 Canadian Blood Services Use of acellular pro-inflammatory compositions and process for making same
WO2015061536A1 (en) 2013-10-25 2015-04-30 Regulus Therapeutics Inc. Microrna compounds and methods for modulating mir-21 activity
EP3079727A1 (en) * 2013-12-12 2016-10-19 INSERM - Institut National de la Santé et de la Recherche Médicale Methods for the prevention and treatment of diabetic cardiomyopathy using mir-424/322
US10561685B2 (en) 2014-07-10 2020-02-18 Canadian Bllood Services Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system
CN107108685B (zh) * 2014-09-08 2020-10-20 米拉根医疗股份有限公司 miR-29模拟物及其用途
HK1249108A1 (zh) 2015-01-20 2018-10-26 米拉根医疗股份有限公司 Mir-92抑制剂及其用途
CN106924757B (zh) * 2015-12-31 2020-07-24 中国科学院遗传与发育生物学研究所 miR-449c-5p及其拟似物在制备治疗和预防心脏瓣膜疾病产品中的应用
CN107034216A (zh) * 2016-02-04 2017-08-11 中国科学技术大学 miRancer分子的设计与应用
KR101835018B1 (ko) 2016-03-03 2018-03-06 고려대학교 산학협력단 엑소좀 또는 엑소좀 유래 리보핵산을 포함하는 간섬유증 예방 또는 치료용 조성물
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
WO2019050071A1 (ko) 2017-09-08 2019-03-14 고려대학교 산학협력단 엑소좀 또는 엑소좀 유래 리보핵산을 포함하는 간섬유증 예방 또는 치료용 조성물
CN107858419A (zh) * 2017-11-10 2018-03-30 青岛大学 miRNA的应用、应用其的产品及检测方法
MY199134A (en) 2018-05-25 2023-10-17 Bioneer Corp Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis related diseases and respiratory diseases, comprising same
CN109498642A (zh) * 2018-12-21 2019-03-22 复旦大学附属中山医院 一种柯萨奇b3病毒感染导致的心脏微血管病变的靶向治疗药物
MX2022012544A (es) 2020-04-09 2022-11-07 Univ Muenchen Tech Liberacion dirigida de un inhibidor de mir-21 a macrofagos para el tratamiento de la fibrosis pulmonar.
WO2021262919A2 (en) 2020-06-26 2021-12-30 The Research Foundation For The State University Of New York 5-halouracil-modified micrornas and their use in the treatment of cancer
WO2022026851A1 (en) * 2020-07-31 2022-02-03 The Scripps Research Institute Targeted rna degradation allows precision repurposing of protein-targeted small molecule medicines to rna
US20240141340A1 (en) * 2021-03-05 2024-05-02 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for use in the treatment of corneal dystrophies
KR102549208B1 (ko) * 2021-04-08 2023-06-30 연세대학교 산학협력단 심혈관 질환과 관련된 LncRNA 및 이의 용도
CN118667869B (zh) * 2024-07-10 2025-06-27 中国水稻研究所 水稻氮素利用基因nu4在调控水稻生长中的应用
EP4741501A1 (en) 2024-11-11 2026-05-13 RNATICS GmbH Dosing of oligonucleotide drugs targeting mir-21 for inhalation
CN122251428A (zh) * 2026-05-27 2026-06-23 天津医科大学第二医院 二甲双胍联合miR-21激动剂在治疗糖尿病性骨质疏松中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050115231A (ko) * 2003-02-10 2005-12-07 내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 포유동물 세포의 조절
AU2004221760B2 (en) * 2003-03-21 2010-03-18 Roche Innovation Center Copenhagen A/S Short interfering RNA (siRNA) analogues
JP2007511487A (ja) * 2003-11-17 2007-05-10 ノバルティス アクチエンゲゼルシャフト ジペプチジルペプチダーゼｉｖ阻害剤の使用
CA2566519C (en) 2004-05-14 2020-04-21 Rosetta Genomics Ltd. Micrornas and uses thereof
EP1827458A4 (en) * 2004-11-09 2010-02-17 Baylor College Medicine SELECTIVE INHIBITION OF ROCK 1 IN HEART THERAPY
US20070213292A1 (en) * 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
CA3042781C (en) * 2006-04-03 2021-10-19 Roche Innovation Center Copenhagen A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
JP2010505427A (ja) 2006-10-09 2010-02-25 ジュリアス−マキシミリアンズ−ユニベルシタット ワーズブルグ 心疾患の診断及び治療用マイクロＲＮＡ（ｍｉＲＮＡ）
EP2104735A2 (en) * 2006-12-08 2009-09-30 Asuragen, INC. Mir-21 regulated genes and pathways as targets for therapeutic intervention
WO2009058818A2 (en) 2007-10-29 2009-05-07 The Board Of Regents Of The University Of Texas System Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
EP2096171A1 (en) 2008-02-27 2009-09-02 Julius-Maximilians-Universität Würzburg MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes

Similar Documents

Publication Publication Date Title
JP2012050438A5 (enExample)
RU2501803C2 (ru) Композиции и способы модуляции экспрессии рецептора фактора роста фибробластов 4 (fgfr4)
JP2012050439A5 (enExample)
JP2011501962A5 (enExample)
JP2014511686A5 (enExample)
JP2012505660A5 (enExample)
JP2010505432A5 (enExample)
JP2009506124A5 (enExample)
JP2010539950A5 (enExample)
HRP20130766T1 (hr) Mikrornk (mirnk) mir-21 za dijagnostiäśke i terapijske svrhe
JP2018199700A5 (enExample)
JP2008514223A5 (enExample)
US8871731B2 (en) Micro-RNA for the regulation of cardiac apoptosis and contractile function
JP2018184423A5 (enExample)
JP2015519891A5 (enExample)
JP2013518605A5 (enExample)
JP2012508560A5 (enExample)
JP2014516516A5 (enExample)
JP2016171800A5 (enExample)
JP2014503192A5 (enExample)
JP2007505627A5 (enExample)
JP2012527444A5 (enExample)
JP2014513954A5 (enExample)
JP2016530882A5 (enExample)
JP2014504857A5 (enExample)